Robbins Geller Rudman & Dowd LLP Announces Deadline for Investors in TransMedics Securities Litigation; Allegations of Kickbacks and Unsafe Practices Surface
SAN DIEGO — A class action lawsuit has been filed against TransMedics Group, Inc., a medical technology company specializing in organ transplant therapy for patients with end-stage organ failure. The complaint, handled by Robbins Geller Rudman & Dowd LLP, involves allegations of securities fraud. Individuals who purchased or acquired TransMedics securities between February 28, 2023, and January 10, 2025, are urged to seek appointment as lead plaintiff by April 15, 2025. The suit, formally titled Jewik v. TransMedics Group, Inc., and filed in the District Court of Massachusetts, accuses TransMedics and some of its executives … Read more